✓The authors present a case of scalp and facial edema following craniofacial reconstruction for metopic craniosynostosis in which recombinant human bone morphogenetic protein–2 (rhBMP-2) was used to treat cranial defects related to the frontoorbital reconstruction. The extent of swelling, the onset, and duration were unusual for such cases and suggested a possible role of rhBMP-2 in inducing a local inflammatory response. The edema rapidly resolved after the patient underwent surgery to remove the rhBMP-2 implants.
Abbreviations used in this paper: BMP = bone morphogenetic protein; FDA = Food and Drug Administration; rhBMP-2 = recombinant human BMP–2.
AkitaSFukuiMNakagawaHFujiiTAkinoK: Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen12:252–2592004
HouRChenFYangYChengXGaoZYangHO: Comparative study between coral-mesenchymal stem cells-rhBMP-2 composite and auto-bone-graft in rabbit critical-sized cranial defect model. J Biomed Mater Res A80:85–932007
JovanovicSAHuntDRBernardGWSpiekermannHWozneyJMWikesjöUM: Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res18:224–2302007
WarrenJKellyB: FDA Unanimously Recommends Approval of Third Indication For Medtronic's INFUSE Bone GraftMemphisMedtronic Media Relations2006. (http://www.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1163111450577&format=pdf&lang=en_US) [Accessed 5 November 2007]
ZhengYXZhaoHYJingXBQinQLGuJJTianN: [Reconstruction of orbital floor defect with polylacticglycolide acid/ recombinant human bone morphogenetic protein 2 compound implanted material in sheep.]. Zhonghua Yan Ke Za Zhi42:535–5392006. (Chn)